Risk dimension: is M&A and strategic partnering amongst pharmaceutical firms risk reducing?: an explorative research involving competition

Additional Metadata
Keywords	Pharmaceutical industry/market/sector, Risk, Mergers and acquisitions (M&A)
Thesis Advisor	Rosch, D.M., Fan, Y.
Persistent URL	hdl.handle.net/2105/25634
Series	Finance & Investments
Organisation	Rotterdam School of Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Roozendaal, H.C.F. (2012, September 13). Risk dimension: is M&A and strategic partnering amongst pharmaceutical firms risk reducing?: an explorative research involving competition. Finance & Investments. Retrieved from http://hdl.handle.net/2105/25634

Risk dimension: is M&A and strategic partnering amongst pharmaceutical firms risk reducing?